Patents by Inventor Jane Xu Kelly

Jane Xu Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200157053
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 21, 2020
    Inventors: Michael Riscoe, Aaron Nilsen, Allison Stickles, Galen Miley, Rolf Winter, Sovitj Pou, Yuexin Li, Jane Xu Kelly, Isaac Forquer, J. Stone Doggett, Igor Bruzual, Lisa Frueh, Rozalia Dodean, Martin Smilkstein, Holland Alday, Dennis Koop, Lisa Bleyle
  • Patent number: 10584098
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: March 10, 2020
    Assignee: Oregon Health & Science University
    Inventors: Michael Riscoe, Aaron Nilsen, Galen Miley, Rolf Winter, Sovitj Pou, Jane Xu Kelly, Rozalia Dodean
  • Patent number: 10532983
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: January 14, 2020
    Assignee: Oregon Health & Science University
    Inventors: Michael Riscoe, Aaron Nilsen, Galen Miley, Rolf Winter, Sovitj Pou, Jane Xu Kelly, Rozalia Dodean
  • Publication number: 20190389802
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Application
    Filed: August 23, 2018
    Publication date: December 26, 2019
    Inventors: Michael Riscoe, Aaron Nilsen, Allison Stickles, Galen Miley, Rolf Winter, Sovitj Pou, Yuexin Li, Jane Xu Kelly, Isaac Forquer, J. Stone Doggett, Igor Bruzual, Lisa Frueh, Rozalia Dodean, Martin Smilkstein, Holland Alday, Dennis Koop, Lisa Bleyle
  • Publication number: 20180362465
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Application
    Filed: August 23, 2018
    Publication date: December 20, 2018
    Inventors: Michael Riscoe, Aaron Nilsen, Allison Stickles, Galen Miley, Rolf Winter, Sovitj Pou, Yuexin Li, Jane Xu Kelly, Isaac Forquer, J. Stone Doggett, Igor Bruzual, Lisa Frueh, Rozalia Dodean, Martin Smilkstein, Holland Alday, Dennis Koop, Lisa Bleyle
  • Patent number: 10023538
    Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: July 17, 2018
    Assignees: The United States of America as represented by the Department of Veterans Affairs, Oregon Health and Science University
    Inventors: Michael K. Riscoe, Rolf W. Winter, Sovitj Pou, David J. Hinrichs, Jane Xu Kelly, Yuexin Li, Aaron Nilsen
  • Publication number: 20180009760
    Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
    Type: Application
    Filed: February 23, 2017
    Publication date: January 11, 2018
    Applicants: Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Michael K. Riscoe, Rolf W. Winter, Sovitj Pou, David J. Hinrichs, Jane Xu Kelly, Yuexin Li, Aaron Nilsen
  • Publication number: 20170022164
    Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.
    Type: Application
    Filed: July 20, 2016
    Publication date: January 26, 2017
    Inventors: Michael Riscoe, Aaron Nilsen, Allison Stickles, Galen Miley, Rolf Winter, Sovitj Pou, Yuexin Li, Jane Xu Kelly, Isaac Forquer, J. Stone Doggett, Igor Bruzual, Lisa Frueh, Rozalia Dodean, Martin Smilkstein, Holland Alday, Dennis Koop, Lisa Bleyle
  • Publication number: 20160340313
    Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
    Type: Application
    Filed: December 21, 2015
    Publication date: November 24, 2016
    Applicants: Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Michael K. Riscoe, Rolf W. Winter, Sovitj Pou, David J. Hinrichs, Jane Xu Kelly, Yuexin Li, Aaron Nilsen
  • Patent number: 9249103
    Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: February 2, 2016
    Assignees: Oregon Health & Science University, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: Michael K. Riscoe, Rolf W. Winter, Sovitj Pou, David J. Hinrichs, Jane Xu Kelly, Yuexin Li, Aaron Nilsen
  • Publication number: 20140350048
    Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.
    Type: Application
    Filed: January 14, 2013
    Publication date: November 27, 2014
    Inventors: Michael K. Riscoe, Rolf W. Winter, Sovitj Pou, David J. Hinrichs, Jane Xu Kelly, Yuexin Li, Aaron Nilsen